satigrel has been researched along with arachidonic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, Y | 1 |
| Fujimori, T; Harada, K; Katayama, K; Kogushi, M; Saeki, T; Yoshimura, T | 1 |
2 other study(ies) available for satigrel and arachidonic acid
| Article | Year |
|---|---|
[Pharmacological aspects of a novel antiplatelet drug, E5510].
Topics: Animals; Arachidonic Acid; Cyclooxygenase Inhibitors; Depression, Chemical; Dogs; Fatty Acids, Monounsaturated; Fibrinolytic Agents; Guinea Pigs; Humans; Male; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Swine; Thrombocythemia, Essential | 1992 |
A new anti-platelet drug, E5510, has multiple suppressive sites during receptor-mediated signal transduction in human platelets.
Topics: Arachidonic Acid; Arachidonic Acids; Binding Sites; Blood Platelets; Calcium; Carbon Radioisotopes; Cyclic AMP; Fatty Acids, Monounsaturated; Fura-2; Humans; Male; Phospholipases A; Phospholipases A2; Phosphoric Diester Hydrolases; Phosphorylation; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Receptors, Cell Surface; Signal Transduction; Thrombin; Thromboxane B2 | 1991 |